Publications by authors named "B Burtness"

Claim this Profile
R
Re-defining Standards of Care in Resectable Head and Neck Squamous Cell Carcinoma - Lessons from KEYNOTE-689 and NIVOPOSTOP.
Saral Mehra, Sue S Yom, Barbara Burtness

Oncologist· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Automated Lymph Node and Extranodal Extension Assessment Improves Risk Stratification in Oropharyngeal Carcinoma.
Zezhong Ye, Reza Mojahed-Yazdi, Anna Zapaishchykova, Divyanshu Tak, Maryam Mahootiha, Barbara A Burtness

J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
Xevinapant or Placebo Plus Platinum-Based Chemoradiotherapy in Unresected Locally Advanced Squamous Cell Carcinoma of the Head and Neck (TrilynX): A Randomized, Phase III Study.
Jean Bourhis, Lisa F Licitra, Barbara Burtness, Amanda Psyrri, Robert Haddad

J Clin Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HERTHENA-PanTumor01: a phase II study of patritumab deruxtecan (HER3-DXd) in previously treated advanced solid tumors.
Thomas Powles, Aarti Bhatia, Barbara Burtness, Takahiro Kogawa, Tomohiro Nishina

Future Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life outcomes from KEYNOTE-412: chemoradiotherapy with or without pembrolizumab in participants with head and neck squamous cell carcinoma.
J-P Machiels, Y Tao, L Licitra, B Burtness, M Tahara

Front Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis